Maximum quantity allowed is 999
请选择数量
CAS RN: 698387-09-6 | 产品编码: N1062
产品编码 | N1062 |
纯度/分析方法 | >95.0%(T)(HPLC) |
分子式/分子量 | C__3__0H__2__9ClN__6O__3 = 557.05 |
外观与形状(20°C) | 固体 |
储存温度 | 冷冻 (<0°C) |
应避免的情况 | 加热 |
包装和容器 | 100MG-Glass Bottle with Plastic Insert (查看图片) |
CAS RN | 698387-09-6 |
Reaxys-RN | 9971763 |
PubChem物质ID | 468592465 |
MDL编号 | MFCD09752958 |
技术规格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Volumetric Analysis) | min. 95.0 % |
Melting point | 182.0 to 186.0 °C |
NMR | confirm to structure |
物性(参考值)
熔点 | 184 °C |
GHS
象形图 |
![]() |
信号词 | Warning |
危险性说明 | H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P271 : Use only outdoors or in a well-ventilated area. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. |
相关法规
运输信息
HS编码* | 2933.49-000 |
应用
Neratinib: A Receptor Tyrosine Kinase Inhibitor of HER1 (EGFR), HER2 and HER4
Neratinib (HKI-272) is a receptor tyrosine kinase inhibitor that irreversibly binds to epidermal growth factor receptors HER1 (EGFR), HER2, and HER4. It has been reported that neratinib reduces EGFR and HER-2 receptor autophosphorylation with inhibition of cell proliferation and functions. Neratinib is highly active against HER2-overexpressing human breast cancer cell lines, and have been mainly used in the treatment of breast cancer. (The product is for research purpose only.)
References
- Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
- Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity
- The development of HKI-272 and related compounds for the treatment of cancer (a review)
- Neratinib: First Global Approval (a review)
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。